• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

mergers and acquisitions

puzzle pieces merger and acquisition business concept
Marketing

Consulting firm Blue Matter picks up comms agency Cognite

The deal stands to "turbocharge" Cognite's global reach and growth opportunities, chief business officer Sean Cush pointed out.
Zoey Becker Oct 28, 2026 10:06am
China flag against blue sky
Favicon Fierce Biotech

China looks to ban foreign acquisitions of key biotech platforms

Oct 16, 2026 10:38am
Illustration connected puzzle pieces with the acronym MA

Galderma targets medical skincare growth with $1.5B Zo buyout

Oct 14, 2026 10:31am
Stivarga

Bayer sells cancer drug Stivarga to Grünenthal for up to $431M

Sep 21, 2026 10:20am
Room

‘No discussions’ ongoing for AstraZeneca-BMS merger: Reuters

Aug 5, 2026 10:12am
MA
Favicon Fierce Biotech

Curium strikes up to $8B deal for radiopharma rival Lantheus

Aug 3, 2026 2:20pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings